Exploring Safety in Gender-Affirming Hormonal Treatments: An Observational Study on Adverse Drug Events Using the Food and Drug Administration Adverse Event Reporting System Database.

IF 2.3 4区医学 Q3 PHARMACOLOGY & PHARMACY

Annals of Pharmacotherapy Pub Date : 2024-09-18 DOI:10.1177/10600280241278913

Michael K Laidlaw, Sarah Jorgensen

引用次数: 0

查看原文本刊更多论文

探索性别确认荷尔蒙疗法的安全性：利用食品和药物管理局不良事件报告系统数据库开展的药物不良事件观察研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Pharmacotherapy 医学-药学

CiteScore

5.70

自引率

0.00%

发文量

166

审稿时长

3-8 weeks

期刊介绍： Annals of Pharmacotherapy (AOP) is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research and review articles to achieve the most desired health outcomes.The articles provide cutting-edge information about the most efficient, safe and cost-effective pharmacotherapy for the treatment and prevention of various illnesses. This journal is a member of the Committee on Publication Ethics (COPE). Average time from submission to first decision: 14 days